Cargando…

Antimicrobial Multidrug Resistance: Clinical Implications for Infection Management in Critically Ill Patients

The increasing incidence of antimicrobial resistance (AMR) worldwide represents a serious threat in the management of sepsis. Due to resistance to the most common antimicrobials prescribed, multidrug-resistant (MDR) pathogens have been associated with delays in adequate antimicrobial therapy leading...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalın, Gamze, Alp, Emine, Chouaikhi, Arthur, Roger, Claire
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609422/ https://www.ncbi.nlm.nih.gov/pubmed/37894233 http://dx.doi.org/10.3390/microorganisms11102575

Ejemplares similares

Current infection prevention and control strategies of COVID-19 in hospitals
por: KALIN ÜNÜVAR, Gamze, et al.
Publicado: (2021)

Multidrug Resistance in Critically Ill Patients: An Unresolved Issue
por: Spadaro, Savino
Publicado: (2023)

Recent Advances in Colorimetric Tests for the Detection of Infectious Diseases and Antimicrobial Resistance
por: Celik, Cagla, et al.
Publicado: (2023)

The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 Infection
por: Alenazi, Thamer A., et al.
Publicado: (2023)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

Comparison of multidrug-resistant Acinetobacter and non-Acinetobacter infections in terms of outcome in critically ill patients
por: Madaan, A, et al.
Publicado: (2014)

Comparison of multidrug-resistant acinetobacter and non-acinetobacter infections in terms of outcome in critically ill patients
por: Madaan, A, et al.
Publicado: (2015)

Multidrug resistant Gram-negative bacilli infection in critically ill patients with Coronavirus disease 2019
por: Allende, N. García, et al.
Publicado: (2022)

Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence
por: Viale, Pierluigi, et al.
Publicado: (2023)

A deep learning model for predicting multidrug-resistant organism infection in critically ill patients
por: Wang, Yaxi, et al.
Publicado: (2023)

Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance
por: Shaikh, Sibhghatulla, et al.
Publicado: (2019)

Editorial: Antimicrobial resistance and therapy in critically ill patients
por: Li, Qi, et al.
Publicado: (2023)

Pharmacy intervention on antimicrobial management of critically ill patients
por: Ijo, Immanuel, et al.
Publicado: (2011)

Clinical prediction models for multidrug-resistant organism colonisation or infection in critically ill patients: a systematic review protocol
por: Wang, Yi, et al.
Publicado: (2022)

Value of American Thoracic Society Guidelines in Predicting Infection or Colonization with Multidrug-Resistant Organisms in Critically Ill Patients
por: Xie, Jianfeng, et al.
Publicado: (2014)

Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April–July 2020
por: Chowdhary, Anuradha, et al.
Publicado: (2020)

Fecal Microbial Transplantation for the Treatment of Persistent Multidrug-Resistant Klebsiella pneumoniae Infection in a Critically Ill Patient
por: Ueckermann, V., et al.
Publicado: (2020)

Metagenomic prediction of antimicrobial resistance in critically ill patients with lower respiratory tract infections
por: Serpa, Paula Hayakawa, et al.
Publicado: (2022)

Management of hypocalcaemia in the critically ill
por: Melchers, Max, et al.
Publicado: (2023)

Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections
por: Ruiz, Jesus, et al.
Publicado: (2020)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

Epidemiology and risk factors for multidrug-resistant bacteria in critically ill patients with liver disease
por: Choudhuri, Anirban Hom, et al.
Publicado: (2018)

The Effect of Infection Control Nurses on the Occurrence of Pseudomonas aeruginosa Healthcare-Acquired Infection and Multidrug-Resistant Strains in Critically-Ill Children
por: Xu, Wei, et al.
Publicado: (2015)

Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
por: Ibrahim, Mohamed M, et al.
Publicado: (2018)

Mortality incidence among critically ill burn patients infected with multidrug-resistant organisms: A retrospective cohort study
por: Ellithy, Moustafa, et al.
Publicado: (2021)

The race for antimicrobials in the multidrug resistance era
por: Molina‐Santiago, Carlos, et al.
Publicado: (2017)

Minocycline: The second important antimicrobial in multidrug-resistant Acinetobacter baumanii infections
por: Nair, Abhijit S.
Publicado: (2018)

The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
por: Shi, Jingru, et al.
Publicado: (2022)

Decision Challenges for Managing Acute Paediatric Infections: Implications for Antimicrobial Resistance
por: Krockow, Eva M., et al.
Publicado: (2023)

Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-Resistant Staphylococcus and Vancomycin-Resistant Enterococcus
por: Turner, Adrianna M., et al.
Publicado: (2021)

MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY
por: Tsuruo, Takashi
Publicado: (1988)

The Effect of Mesenchymal Stromal Cells on the Mortality of Patients with Sepsis and Septic Shock: A Promising Therapy
por: Alp, Emine, et al.
Publicado: (2022)

The Role of Antimicrobial Peptides in Preventing Multidrug-Resistant Bacterial Infections and Biofilm Formation
por: Park, Seong-Cheol, et al.
Publicado: (2011)

Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials
por: Sousa, Sílvia A., et al.
Publicado: (2021)

Impact of COVID-19 on Antimicrobial Consumption and Spread of Multidrug-Resistance in Bacterial Infections
por: Jeon, Kibum, et al.
Publicado: (2022)

SECONDARY BACTERIAL INFECTION WITH MULTIDRUG-RESISTANT PATHOGENS WAS COMMON IN INTUBATED CRITICALLY ILL PATIENTS WITH COVID-19: WHAT ARE PREDICTORS FOR POOR OUTCOMES?
por: SADIGOV, ALIZAMAN, et al.
Publicado: (2021)

In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii
por: Percin, Duygu, et al.
Publicado: (2014)

Effect of antimicrobial administration on fecal microbiota of critically ill dogs: dynamics of antimicrobial resistance over time
por: Menard, Julie, et al.
Publicado: (2022)

Impact of multidrug resistance on the management of bacterial infections in cirrhosis
por: Terra, Carlos, et al.
Publicado: (2023)

Antimicrobial stewardship in the intensive care unit
por: Ture, Zeynep, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_id8e3igkfenati9quo0gkeh2kr